DMK

David M. Knott Portfolio holdings

AUM $264M
This Quarter Return
+17.08%
1 Year Return
+57.14%
3 Year Return
+78.48%
5 Year Return
+218.77%
10 Year Return
–
AUM
$234M
AUM Growth
+$234M
Cap. Flow
-$25.8M
Cap. Flow %
-11.02%
Top 10 Hldgs %
47.79%
Holding
149
New
39
Increased
14
Reduced
25
Closed
20

Top Buys

1
AGAC.U
African Gold Acquisition Corporation Units, each consisting of one Class A ordinary share and three-quarters of one redeemable warrant
AGAC.U
$6.11M
2
TWLVU
Twelve Seas Investment Company II Unit
TWLVU
$5.07M
3
GLHAU
Glass Houses Acquisition Corp. Unit
GLHAU
$5.02M
4
LOKM.U
Live Oak Mobility Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-fifth of one warrant
LOKM.U
$3.59M
5
KAIR
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
$2.55M

Top Sells

1
LGND icon
Ligand Pharmaceuticals
LGND
$26.4M
2
DNMR
Danimer Scientific, Inc.
DNMR
$11.3M
3
FTAI icon
FTAI Aviation
FTAI
$5.64M
4
UPLD icon
Upland Software
UPLD
$5.03M
5
LKQ icon
LKQ Corp
LKQ
$4.23M

Sector Composition

1 Healthcare 27.07%
2 Financials 22.62%
3 Materials 11.65%
4 Technology 6.59%
5 Communication Services 6.17%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TGTX icon
26
TG Therapeutics
TGTX
$4.65B
$2.51M 1.07% 51,973 +1,200 +2% +$57.8K
AVDL
27
Avadel Pharmaceuticals
AVDL
$1.43B
$2.47M 1.06% 272,845 +185,929 +214% +$1.68M
EIGR
28
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$2.45M 1.05% 276,535 -18,500 -6% -$164K
UTHR icon
29
United Therapeutics
UTHR
$13.8B
$2.43M 1.04% +14,500 New +$2.43M
JPM icon
30
JPMorgan Chase
JPM
$829B
$2.36M 1.01% 15,470 -4,500 -23% -$685K
ZGNX
31
DELISTED
Zogenix, Inc.
ZGNX
$2.3M 0.98% 117,688 +4,981 +4% +$97.2K
TRIL
32
DELISTED
Trillium Therapeutics Inc.
TRIL
$2.13M 0.91% 198,699 +24,000 +14% +$258K
HZAC
33
DELISTED
Horizon Acquisition Corporation
HZAC
$2.08M 0.89% 210,100 – –
AB icon
34
AllianceBernstein
AB
$4.38B
$2.02M 0.86% 50,500 – –
AUPH icon
35
Aurinia Pharmaceuticals
AUPH
$1.58B
$2.01M 0.86% 154,840 -22,700 -13% -$295K
CNST
36
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$2.01M 0.86% 85,909 +52,909 +160% +$1.24M
MSACU
37
DELISTED
Medicus Sciences Acquisition Corp. Unit
MSACU
$1.97M 0.84% +200,000 New +$1.97M
PMGM
38
DELISTED
Priveterra Acquisition Corp. II Class A Common Stock
PMGM
$1.95M 0.83% +200,000 New +$1.95M
BRPMU
39
DELISTED
B. Riley Principal 150 Merger Corp. Unit
BRPMU
$1.76M 0.75% +175,963 New +$1.76M
BRSL
40
Brightstar Lottery PLC
BRSL
$3.15B
$1.73M 0.74% 107,500 – –
KAIRW
41
DELISTED
Kairos Acquisition Corp. Warrant
KAIRW
$1.5M 0.64% +130,687 New +$1.5M
ASLN
42
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$1.47M 0.63% +437,412 New +$1.47M
CHRS icon
43
Coherus Oncology, Inc. Common Stock
CHRS
$135M
$1.46M 0.62% 99,655 -2,000 -2% -$29.2K
QURE icon
44
uniQure
QURE
$896M
$1.41M 0.6% 41,766 +6,766 +19% +$228K
VKTX icon
45
Viking Therapeutics
VKTX
$3.04B
$1.32M 0.56% 208,102 -10,000 -5% -$63.2K
VRCA icon
46
Verrica Pharmaceuticals
VRCA
$52.8M
$1.19M 0.51% 78,424 +1,839 +2% +$27.9K
PMGMW
47
DELISTED
Priveterra Acquisition Corp. II Warrant to purchase Class A common stock
PMGMW
$1.15M 0.49% +100,000 New +$1.15M
CDTX icon
48
Cidara Therapeutics
CDTX
$1.66B
$1.11M 0.47% 415,308 – –
VZ icon
49
Verizon
VZ
$186B
$1.03M 0.44% 17,711 -600 -3% -$34.9K
ROCRU
50
DELISTED
Roth CH Acquisition III Co. Unit
ROCRU
$1M 0.43% +100,000 New +$1M
1
2
3 4 5